White Paper | June 19, 2008
White Paper: Regulation 21 CFR Part 210-211
Source: Pilgrim Software Inc.
The demand for healthcare products is ever increasing as the landscape of modern society evolves. These trends are reshaping the Pharmaceutical and Biologics industries. With the demand for products, comes the concern among pharma-bio manufacturers for regulatory scrutiny.

